Osaic Holdings
VERA icon

Osaic Holdings’s Vera Therapeutics VERA Stock Holding History

Osaic Holdings’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2
Closed -$496 – 7548
2023
Q2 		$496 Buy
+2
New +$18 ﹤0.01% 7054

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Osaic Holdings's VERA Position: Q2 2026 in Review

Osaic Holdings increased its Vera Therapeutics (VERA) stake by 162% in Q2 2026, buying an estimated $62.5K and bringing the position to 2,709 shares worth $116K. The position accounts for ﹤0.01% of the portfolio, ranked #4824.

Osaic Holdings first reported a position in VERA in Q2 2024 and has held it in 8 quarters since. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Osaic Holdings held 2,709 shares of Vera Therapeutics worth $116K as of Q2 2026.
  • Osaic Holdings bought 1,676 Vera Therapeutics shares in Q2 2026, an estimated $62.5K.
  • Vera Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #4824 holding.
  • Osaic Holdings first reported a position in Vera Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.